In patients with diabetic macular edema, small gauge pars plana vitrectomy should be considered as a first-line treatment, ...

First quarter 2026 revenues increased 19% to $3.6 billion versus first quarter 2025Dupixent- global net sales (recorded by Sanofi) increased 33% to $4.9 billion EYLEA HD- U.S. net sales increased 52% ...

Earnings call Regeneron delivered a robust Q1 2026, with total revenue up 19% year-over-year and non-GAAP EPS up 15%, driven by strong Dupixent and EYLEA HD growth. Management reiterated confidence in ...

Regeneron Pharmaceuticals REGN has entered into a strategic research collaboration with clinical-stage biopharmaceutical ...

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

A new study published in the Journal of the American Medical Association found that administration of anti–vascular ...

A detailed new map of the human kidney revealed a previously unrecognized form of diabetic kidney disease (DKD) marked by clusters of immune cells—specifically B cells—that are linked to faster ...

Enrollment underway in SOL-X long-term extension trial in wet AMD for subjects completing two-year follow-up in SOL-1 or SOL-RAnnounced positive ...

Type 1 diabetes progresses through 3 stages: autoantibodies appear first (stage 1), then blood sugar rises without symptoms (stage 2), and finally symptoms like excessive thirst, frequent urination, ...

Millions of older Americans may have access for the first time to obesity drugs at a low price of $50 a month starting in ...

Primary care practitioners serve a critical role in optimizing clinical outcomes for adults with T2DM by evaluating underlying mechanisms, treatment efficacy, medication safety profiles, and ...